Management of Solitary Pulmonary Nodules

Initial Imaging Evaluation

The American College of Radiology recommends obtaining a thin-section chest CT without IV contrast (1.5 mm slices with multiplanar reconstructions) as the next step for a 1 cm solitary pulmonary nodule in a 63-year-old smoker, followed by risk stratification to determine whether PET/CT, biopsy, or surveillance is most appropriate 1, 2
CT chest without IV contrast is the gold standard for evaluating this 1 cm nodule, as it is 10-20 times more sensitive than standard radiography and allows optimal nodule characterization 2, 3
Thin-section imaging (1.5 mm slices) with multiplanar reconstructions should be used to accurately assess nodule size, morphology, margins, density, and presence of calcification 1, 2
IV contrast is not required to identify, characterize, or determine stability of pulmonary nodules 1, 2

For solid nodules >8 mm with high pretest probability of malignancy (>65%): proceed directly to tissue diagnosis via biopsy or surgical resection without PET scanning 3
Patient factors increasing malignancy risk include: 63-year-old age, smoking history, nodule size of 1 cm 2, 4
For solid nodules >8 mm with low-to-moderate pretest probability (5-65%): FDG-PET/CT is appropriate to further characterize the nodule before deciding on biopsy versus surveillance 3, 4

The American College of Radiology recommends calculating pretest probability of malignancy using clinical judgment incorporating age, smoking history, nodule size, and nodule morphology from CT 1, 2, 4
For high probability (>65%): image-guided transthoracic needle biopsy or surgical resection is recommended 3, 4
For moderate probability (5-65%): FDG-PET/CT followed by biopsy if PET-positive is recommended 3, 4

The combination of 1 cm size and smoking history places this patient at elevated risk for malignancy, making active evaluation (not just surveillance) appropriate 2, 4
The Fleischner Society and ACCP guidelines recommend follow-up CT at specific intervals, PET/CT, tissue sampling, or combinations depending on individual factors for nodules ≥6 mm 1
Biopsy is suggested as one potential next step for indeterminate nodules >8 mm, which applies to this 1 cm nodule 1, 4

Do not rely on chest radiography for follow-up, as most nodules <1 cm are not visible and sensitivity is poor 1, 2
Do not use thick-section CT for follow-up; standardized thin-section protocols (1.5 mm) are essential to avoid measurement errors 1, 2
Do not skip risk assessment—discuss risks and benefits of management strategies (surveillance vs. biopsy vs. surgery) with the patient and incorporate their preferences 1, 3